Monthly Archives: October 2022

27Oct/22

An Effective BRD4 Protein Degrader Nanodrug for Glioma Therapy

October 27, 2022Protein Degrader News, Protein Degrader ResearchBRD4 Protein Degrader, Gliomabiolabs

Glioma is a primary intracranial malignant tumor originating from glial cells or progenitor cells, accounting for 25.5% of central nervous system tumors. Clinically, the treatment of glioma mainly depends on surgical resection,Read More…

10Oct/22

New Breakthrough in Anti-Cancer! Protein Degrader has Obtained Preclinical Proof of Concept for T-ALL Treatment

October 10, 2022Protein Degrader News, Protein Degrader ResearchCancer, E3 ligase, T-ALL, Targeted Protein Degraderbiolabs

Acute lymphoblastic leukemia (ALL) is a common disease. B-ALL and T-ALL account for 85% and 15% of the two lymphatic lineages of ALL, respectively, but patients with T-ALL have poor life qualityRead More…

Protein Degrader Research
Protein Degrader News